Related Experiment Video
Updated: Jan 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Effects of Thyroid Hormone Replacement Therapy on Lipid Profiles in Patients With Hypothyroidism
Faryal Akhtar1, Muhammad Akram Khan2, Asad Saleem3
1Acute Medicine, County Hospital, Stafford, GBR.
Background:
Hypothyroidism is associated with dyslipidemia and increased cardiovascular risk. Thyroid hormone replacement therapy (THRT) restores thyroid function and may improve lipid metabolism. This study evaluated the effects of THRT on lipid profiles in hypothyroid patients and identified predictors of cardiovascular risk reduction.
Methods:
A retrospective analysis was conducted on 350 patients with hypothyroidism (183 females, 52.3%; 167 males, 47.7%). The mean age was 48.6 ± 13.2 years (range 18-82). The mean BMI was 27.4 ± 4.9 kg/m², with 105 (30.0%) normal weight, 145 (41.4%) overweight, and 100 (28.6%) obese. At baseline, mean thyroid-stimulating hormone (TSH) was 16.3 ± 7.4 mIU/L and free thyroxine (FT4) was 0.84 ± 0.32 ng/dL. Lipid levels showed dyslipidemia: total cholesterol (TC): 238.5 ± 42.3 mg/dL, low-density lipoprotein cholesterol (LDL-C): 142.8 ± 31.5 mg/dL, high-density lipoprotein cholesterol (HDL-C): 44.7 ± 9.5 mg/dL, and triglycerides (TG): 176.4 ± 56.2 mg/dL.
Results:
After an average treatment duration of 18.4 ± 8.7 months, significant reductions were observed in TC (201.3 ± 36.5 mg/dL; -37.2 mg/dL, p < 0.001), LDL-C (118.6 ± 27.2 mg/dL; -24.2 mg/dL, p < 0.001), and TG (156.1 ± 51.3 mg/dL; -20.3 mg/dL, p < 0.001). HDL-C improved modestly (47.9 ± 10.4 mg/dL; +3.2 mg/dL, p < 0.001). Greater benefits were seen in patients with high baseline TSH and LDL-C. Patients with diabetes (n = 102, 29.1%), hypertension (n = 84, 24.0%), or both (n = 67, 19.1%) had lower rates of lipid improvement compared with those without comorbidities (n = 97, 27.7%). Machine learning models demonstrated modest accuracy (receiver operating characteristic curve-area under the curve (ROC-AUC): 0.51-0.56) but confirmed baseline lipids, thyroid hormones, comorbidities, and medication type as key predictors.
Conclusion:
THRT significantly improved lipid profiles and reduced cardiovascular risk in hypothyroid patients, supporting its role as a cornerstone of comprehensive management.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Atherosclerosis III: Management
